💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for EXACT Sciences Corporation (EXAS)
« Back to company indexEXAS Chatter Timeline
Stock Ticker for EXAS
Most Active Tweeters for EXAS
| User | Tweets |
|---|---|
| @FlashAlert_me | 9 |
| @ShortAlgoTrades | 8 |
| @StockAlarms | 8 |
| @InsiderAlerts4U | 7 |
| @thudderwicks | 4 |
Recent Tweets for EXAS
 |
@ShortAlgoTrades $EXAS Trading Ideas | Awaiting Short signal. 85.71% Profitability based on 16 trades. Profit factor is 14.85. Learn… https://t.co/o7rgOuABys June 25th 2022, 3:06am |
 |
@SweepCastApp SweepCast ? Unusual Options Observed : $EXAS with our scanner on $115 PUT Expiring: 01/20/2023 worth 43K? Start Yo… https://t.co/ohVxsgAXFE June 25th 2022, 1:06am |
 |
@wagnermr14 Bought a ton on $exas today June 24th 2022, 3:06pm |
 |
@fibbonacii RT @elleryinsights: Interesting options buying on $nvta today, given their burn and depressed equity, does $exas buy them now? https://t.c… June 24th 2022, 3:06pm |
 |
@elleryinsights Interesting options buying on $nvta today, given their burn and depressed equity, does $exas buy them now? https://t.co/GtEYgZ8iGd June 24th 2022, 3:06pm |
 |
@andrewross11 $exas sold 1/3 of long (500) @ 42.95-.96; 1k shares remaining! June 24th 2022, 2:06pm |
 |
@ShortAlgoKing $EXAS Awaiting Short signal. 91.67% Win rate based on 16 trades. Profit factor is 20.09. ? Begin a Free Trial on… https://t.co/5tWSJnx5gZ June 24th 2022, 12:06pm |
 |
@mediasentiment $EXAS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 50 June 24th 2022, 8:06am |
 |
@frontierx5 $EXAS ... June 24th 2022, 1:06am |
 |
@hunter62046908 $EXAS ~:Top analyst price target today,. https://t.co/OsCHYh8F00 June 23rd 2022, 8:06pm |
|
@ShortAlgoTrades $EXAS Trading Ideas | Awaiting Short signal. 91.67% Profitability based on 16 trades. Profit factor is 20.09. Learn… https://t.co/HPI4VynSwp June 23rd 2022, 2:06pm |
 |
@TortozaPalma $EXAS Awaiting Buy Signal. Learn more at https://t.co/OB4KuLJjyA https://t.co/x75Q1PTl9T June 22nd 2022, 9:06pm |
|
@ShortAlgoTrades $EXAS Trading Ideas | Awaiting Buy signal. 92.86% Profitability based on 18 trades. Profit factor is 5.88. Learn mo… https://t.co/T6LZRPijFh June 22nd 2022, 7:06pm |
 |
@JMarsh48 @DCDOWORK Buy 50 shares $EXAS June 22nd 2022, 7:06pm |
 |
@YuZhu4 RT @TohJah7809: $EXAS Exact x Ultima Genomics ? https://t.co/WAZzsacNTo June 22nd 2022, 4:06pm |
 |
@TohJah7809 $EXAS Exact x Ultima Genomics ? https://t.co/WAZzsacNTo June 22nd 2022, 4:06pm |
 |
@MehtaManal Brilliant strategic move by @KevinConroyCEO of $EXAS by locking in cheap sequencing with @UltimaGenomics, becoming… https://t.co/4uPPZHwBlR June 22nd 2022, 2:06am |
 |
@Gonzalo_sinH $EXAS (NASDAQ) Stock Rating Changed to Hold: Exact Sciences Corp.Ticker is 27.63% off the historical support price.… https://t.co/fDOxYAi5EM June 21st 2022, 5:06pm |
 |
@MedtechTinaTan RT @fwhealthtech: Exact Sciences taps Ultima as gene sequencing partner for cancer Dx https://t.co/ism37JyQZL $EXAS #genomics #genesequenc… June 21st 2022, 3:06pm |
 |
@fwhealthtech Exact Sciences taps Ultima as gene sequencing partner for cancer Dx https://t.co/ism37JyQZL $EXAS #genomics… https://t.co/qY84RjhDYW June 21st 2022, 3:06pm |
 |
@BinfoTrends RT @AlbertVilella: On a related note, $EXAS Exact Sciences enters agreement with @UltimaGenomics #LiquidBiopsy #CancerScreening #NGS #cfDNA… June 21st 2022, 2:06pm |
 |
@Gambiste1 RT @thudderwicks: $EXAS said it has entered into a long-term supply agreement with Ultima Genomics Inc. for Ultima's next-generation sequen… June 21st 2022, 2:06pm |
|
@Gambiste1 RT @thudderwicks: The companies also plan to develop one or more of $EXAS advanced cancer diagnostic tests using Ultima's sequencing techno… June 21st 2022, 2:06pm |
 |
@thudderwicks $EXAS +6.5% June 21st 2022, 2:06pm |
|
@thudderwicks The companies also plan to develop one or more of $EXAS advanced cancer diagnostic tests using Ultima's sequencing technology. June 21st 2022, 2:06pm |
 |
@AlbertVilella On a related note, $EXAS Exact Sciences enters agreement with @UltimaGenomics #LiquidBiopsy #CancerScreening #NGS… https://t.co/X3LOXRI78L June 21st 2022, 2:06pm |
|
@thudderwicks $EXAS said it has entered into a long-term supply agreement with Ultima Genomics Inc. for Ultima's next-generation… https://t.co/ZRRNLiIJcC June 21st 2022, 2:06pm |
|
@thudderwicks $EXAS, Ultima Genomics enter long-term supply agreement for NGS https://t.co/4Y9ubb6g32 June 21st 2022, 2:06pm |
 |
@E1z718 @BullishRippers $Exas June 21st 2022, 1:06pm |
 |
@StocksoftheDay_ $EXAS News Screener Alert: The price is up after the recent publication posted about 3 hours ago .… https://t.co/9f0Uq00yut June 21st 2022, 1:06pm |
 |
@AlertTrade RT @Briefingcom: $EXAS: Exact Sciences entered a long-term supply agreement for Ultima's next-generation sequencing technologies https://t.… June 21st 2022, 12:06pm |
 |
@Briefingcom $EXAS: Exact Sciences entered a long-term supply agreement for Ultima's next-generation sequencing technologies https://t.co/cgitfLgRLo June 21st 2022, 12:06pm |
 |
@datadili Exact Sciences Corporation is up 4.24% in the pre-market $EXAS June 21st 2022, 11:06am |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in EXACT SCIENCES $EXAS https://t.co/XGsLTEzxoG June 21st 2022, 11:06am |
 |
@FastestAlert $EXAS Ultima Genomics And Exact Sciences Enter Long-term Supply Agreement Aimed At Improving Patient Access To Geno… https://t.co/EknVr43CQh June 21st 2022, 10:06am |
 |
@StockNewsBot2 $EXAS Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to geno… https://t.co/qzjuJuKf0R June 21st 2022, 10:06am |
 |
@FlashAlert_me $EXAS [15s. delayed]: Issued Press Release on June 21, 06:00:00: Ultima Genomics and Exact Sciences enter long-term… https://t.co/g6icW4BCji June 21st 2022, 10:06am |
 |
@stock_titan $EXAS Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to geno… https://t.co/kMn01xSR4U June 21st 2022, 10:06am |
 |
@WebChronicleTo1 $EXAS Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to geno… https://t.co/8myBEOSfMs June 21st 2022, 10:06am |
 |
@ShortAlgoTrades $EXAS Trading Ideas | Awaiting Buy signal. 83.33% Profitability based on 6 trades. Profit factor is 12.45. Learn mo… https://t.co/VNEcCIu1d1 June 20th 2022, 8:06pm |
 |
@LeeSinTrade1 $EXAS Awaiting Buy signal. 75% Win rate based on 5 trades. Profit factor is 23.9. ? Begin a Free Trial on… https://t.co/gtdofu03Fc June 20th 2022, 12:06pm |
 |
@Tickeron $EXAS enters a Downtrend because Momentum Indicator dropped below the 0 level on June 9, 2022. View odds for this a… https://t.co/ZqY0MH02VA June 20th 2022, 10:06am |
|
@E1z718 @CathieDWood $exas I'm loading the boat June 19th 2022, 12:06am |
 |
@MarketChmln $EXAS upcoming event June 21: Nephron Liquid Biopsy Innovation Symposium. Options expiring on June 24 that cover th… https://t.co/s48bi5DBXU June 18th 2022, 7:06pm |
|
@ShortAlgoTrades $EXAS Trading Ideas | Awaiting Buy signal. 83.33% Profitability based on 6 trades. Profit factor is 12.45. Learn mo… https://t.co/OifKUrevXG June 18th 2022, 4:06pm |
|
@datadili Exact Sciences Corporation traded 48% above average volume, $EXAS closed up 3.96% June 17th 2022, 8:06pm |
|
@ShortAlgoTrades $EXAS Trading Ideas | Awaiting Buy signal. 75% Profitability based on 5 trades. Profit factor is 23.9. Learn more a… https://t.co/SOIz59wNPY June 17th 2022, 8:06pm |
 |
@MC_OptionTrades $EXAS 24-Jun-22 Straddle Implies a ±9.1% move. Jun 21 Nephron Liquid Biopsy Innovation Symposium https://t.co/9lcRer8HLG June 17th 2022, 7:06pm |
 |
@asoltani8 Lastly, $EXAS says that their MCED test cannot identify cancer cell of origin and requires a PET-CT right now. This… https://t.co/vQ3OAjm6CL June 17th 2022, 5:06pm |
|
@asoltani8 Also the sensitivity of the $EXAS blood based test for CRC was low (60%) vs 82% for GRAIL. ? https://t.co/73PPQ6yYkn June 17th 2022, 5:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.